Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > BTLA

BTLA

Brief Information

Name:B- and T-lymphocyte attenuator
Target Synonym:BTLA,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,B And T Lymphocyte Associated,CD272 Antigen,BTLA1,CD272
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
SCCHO-ATP110 Human CHO/Human BTLA Stable Cell Line Development Service
BTA-H5254 Human Human BTLA (31-150) (M105V, G138S, V148M) Protein, Fc Tag (MALS verified)
BTA-H5254-structure
BTA-H5254-sds
BTA-H82E4 Human Biotinylated Human BTLA (31-150) Protein, His,Avitag™ (MALS verified)
BTA-H82E4-structure
BTA-H82E4-sds
BTA-H82F5 Human Biotinylated Human BTLA (31-150) (M105V, G138S, V148M) Protein, Fc,Avitag™ (MALS verified)
BTA-H82F5-structure
BTA-H82F5-sds
BTA-H52H5 Human Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified)
BTA-H52H5-structure
BTA-H52H5-sds
BTA-H82E5 Human Biotinylated Human BTLA (31-150) (M105V, G138S, V148M) Protein, His,Avitag™ (MALS verified)
BTA-H82E5-structure
BTA-H82E5-sds
BTA-H52H3 Human Human BTLA (31-150) Protein, His Tag (MALS verified)
BTA-H52H3-structure
BTA-H52H3-sds
BTA-H5258 Human Human BTLA (31-150) Protein, Mouse IgG2a Fc Tag (MALS verified)
BTA-H5258-structure
BTA-H5258-sds
BTA-H82F3 Human Biotinylated Human BTLA (31-150) Protein, Fc,Avitag™ (MALS verified)
BTA-H82F3-structure
BTA-H82F3-sds
BTA-H82F8 Human Biotinylated Human BTLA (31-134) Protein, Fc,Avitag™
BTA-H82F8-structure
BTA-H82F8-sds
BTA-M5253 Mouse Mouse BTLA Protein, Fc Tag (MALS verified)
BTA-M5253-structure
BTA-M5253-sds
BTA-M52E2 Mouse Mouse BTLA Protein, His Tag
BTA-M52E2-structure
BTA-M52E2-sds
BTA-H5256 Human Human BTLA (31-150) Protein, Fc Tag (MALS verified)
BTA-H5256-structure
BTA-H5256-sds
BTA-H5255 Human Human BTLA (31-134) Protein, Fc Tag
BTA-H5255-structure
BTA-H5255-sds
ACRO Quality

Synonym Name

BTLA,CD272

Background

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

Clinical and Translational Updates

Related Molecule

HVEM B7-H4

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tifcemalimab TAB-004; JS-004 Phase 3 Clinical Shanghai Junshi Biosciences Co Ltd Solid tumours; Head and Neck Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Hodgkin Disease; Nasopharyngeal Carcinoma; Lymphoma; Lung Neoplasms; Melanoma; Neoplasm Metastasis Details
ANB-032 ANB-032 Phase 2 Clinical Anaptysbio Inc Inflammation; Dermatitis, Atopic; Eczema Details
Venanprubart LY-3361237 Phase 2 Clinical Sanford-Burnham Medical Research Institute, Eli Lilly And Company Sjogren's Syndrome; Lupus Erythematosus, Systemic; Psoriasis Details
MB-272 MB272; GS-0272 Phase 1 Clinical University Of Oxford Arthritis, Rheumatoid; Autoimmune Diseases; Lupus Erythematosus, Systemic Details
HFB-200603 HFB-200603 Phase 1 Clinical HiFiBiO Therapeutics Carcinoma, Renal Cell; Stomach Neoplasms; Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Tifcemalimab TAB-004; JS-004 Phase 3 Clinical Shanghai Junshi Biosciences Co Ltd Solid tumours; Head and Neck Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Transitional Cell; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Hodgkin Disease; Nasopharyngeal Carcinoma; Lymphoma; Lung Neoplasms; Melanoma; Neoplasm Metastasis Details
ANB-032 ANB-032 Phase 2 Clinical Anaptysbio Inc Inflammation; Dermatitis, Atopic; Eczema Details
Venanprubart LY-3361237 Phase 2 Clinical Sanford-Burnham Medical Research Institute, Eli Lilly And Company Sjogren's Syndrome; Lupus Erythematosus, Systemic; Psoriasis Details
MB-272 MB272; GS-0272 Phase 1 Clinical University Of Oxford Arthritis, Rheumatoid; Autoimmune Diseases; Lupus Erythematosus, Systemic Details
HFB-200603 HFB-200603 Phase 1 Clinical HiFiBiO Therapeutics Carcinoma, Renal Cell; Stomach Neoplasms; Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap